Skip to main content
Michael Miller, MD, Pathology, New York, NY, NewYork-Presbyterian/Columbia University Irving Medical Center

MichaelL.MillerMDPhD(He/Him)

Pathology New York, NY

Molecular Genetics, Neuropathology, Anatomic Pathology, Clinical Informatics

Assistant Professor of Pathology at CUMC

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Miller's full profile

Already have an account?

  • Office

    Vagelos College of Physicians and Surgeons at Columbia University
    630 West 168th Street, PH15-124
    New York, NY 10032
    Phone+1 212-305-4531
    Fax+1 212-305-4548
  • Is this information wrong?

Summary

  • As of July 2022, I am an attending neuropathologist at the NewYork–Presbyterian Hospital/Columbia University Irving Medical Center, with an appointment as assistant professor of pathology in the Department of Pathology and Cell Biology at the Vagelos College of Physicians and Surgeons.

    In June 2022, I completed my post-graduate clinical training in both anatomic pathology and neuropathology, both at Columbia University Irving Medical Center through their combined AP/NP residency-fellowship training program.

    In May 2018, I completed my graduate training in the Icahn School of Medicine at Mount Sinai's (ISMMS) medical-scientist training program (MSTP), receiving doctoral degrees in medicine and neuroscience. My doctoral thesis in Neuroscience, successfully presented to my committee in Spring 2016, was conducted in the Laboratory of Molecular Neuropsychopharmacology, Friedman Brain Institute, under the supervision of Yasmin L. Hurd, professor of Psychiatry, Neuroscience and Pharmacology at the Icahn School of Medicine at Mount Sinai, and director of the Addiction Institute at Mount Sinai.

    I graduated from Binghamton University in 2010 with degrees in Biochemistry and Integrative Neuroscience, and a certificate in evolutionary studies.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 2020 - 2022
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 2018 - 2020
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2018, MD, PhD
  • Binghamton University
    Binghamton UniversityBS, Integrative Neuroscience, biochemistry and evolutionary studies, Summa Cum Laude, 2006 - 2010

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2021 - 2023

Awards, Honors, & Recognition

  • Shelanski Research Innovation Award Department of Pathology and Cell Biology, 2021
  • Ruth L. Kirschstein National Research Service Award Fellowship National Institute on Drug Abuse, 2015-2018
  • Goldwater Scholar The Barry M. Goldwater Scholarship and Excellence in Education Foundation, 2009

Publications & Presentations

PubMed

Press Mentions

  • A Gene Links Impulsivity and Drug Use Vulnerability
    A Gene Links Impulsivity and Drug Use VulnerabilityJune 14th, 2018
  • Michael Miller Wins 2021 Shelanski Research Innovation Award in Pathology
    Michael Miller Wins 2021 Shelanski Research Innovation Award in PathologyAugust 23rd, 2022

Grant Support

  • Identifying distinct striatonigral and striatopallidal disturbancesNational Institute on Drug Abuse (NIDA/NIH)2015–2018

Professional Memberships

  • Neuroplex
    Member
  • AANP
    Member

Hospital Affiliations